Innovations in Pancreatic Cancer Management: Multidisciplinary Approaches

Overview

Recent advances in pancreatic cancer management include novel systemic therapies, MR-guided radiation, minimally invasive surgery, and irreversible electroporation (IRE). Multidisciplinary tumor boards are crucial for individualized patient selection between surgical and nonsurgical options, improving survival and quality of life.

Background

Pancreatic cancer remains a highly lethal disease with historically poor prognosis. However, survival rates have modestly improved over the last decade due to advances in systemic and local therapies. Accurate staging using imaging modalities like MRI enhances detection of tumor extent and metastatic disease, guiding treatment decisions. Multidisciplinary care involving surgeons, medical oncologists, and interventional radiologists is essential to optimize outcomes.

Data Highlights

An 80-year-old woman with borderline resectable pancreatic head adenocarcinoma presented with a 2.7 x 2.0 cm mass abutting the superior mesenteric vein (SMV) less than 180 degrees, with associated SMV narrowing. Laboratory values included CA 19-9 just over 300 and CEA 2.6. MRI was utilized for staging, demonstrating advantages over CT in tissue characterization and detection of liver lesions.

Key Findings

• MRI provides superior soft tissue contrast and sensitivity for detecting liver metastases compared to CT, aiding in accurate staging and surgical planning.
• Borderline resectable pancreatic cancer is characterized by limited vascular involvement (e.g., <180° SMV abutment), influencing surgical candidacy and margin status concerns.
• Multidisciplinary tumor boards facilitate individualized treatment decisions, balancing surgery, systemic therapy, and local ablative options like IRE.
• Systemic therapies and local treatments have evolved, contributing to modest survival improvements while maintaining quality of life.
• Minimally invasive surgical approaches and MR-guided radiation therapy represent emerging innovations in pancreatic cancer care.

Clinical Implications

Clinicians should incorporate high-quality MRI in the staging workup of pancreatic cancer to better assess resectability and detect occult metastases. Multidisciplinary evaluation is critical to tailor treatment strategies, including neoadjuvant therapies for borderline resectable cases to improve surgical outcomes. Awareness of novel local ablative techniques and systemic options can expand therapeutic choices for unresectable disease.

Conclusion

Innovations in imaging, systemic therapy, and local treatment modalities are progressively enhancing the management of pancreatic cancer. Multidisciplinary collaboration remains key to optimizing patient selection and improving prognosis in this challenging disease.

References

1. Chuong et al. 2023 -- Innovations in the Management of Pancreatic Cancer